Wednesday, April 18, 2018 11:08:57 AM
"TEL AVIV, Israel and BETHESDA, Maryland, April 18, 2018 /PRNewswire/ --
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in cannabinoid diagnostics for the personalized treatment of cancer, today announced the receipt of a Notice of Allowance from The Patent Office of the State of Israel. The Patent Office intends to grant Cannabics the patent for its method of high throughput screening of cancer cells. The patent encompasses the technology required to produce data on the interaction between different cannabinoids and cancer cells. The high throughput screening tests the effects of a multitude of compounds derived from the cannabis plant on cancer cell lines and biopsies.
"Our aim is to build the intellectual property necessary to personalize cannabinoid diagnostics and treatment for cancer patients," said Dr. Eyal Ballan, Cannabics co-founder and chief technology officer. "We are compiling data that demonstrates that cannabinoids are not only effective in treating the symptoms of cancer and its therapies, but also in fighting the cancer itself. The patent from the State of Israel is an important step towards leveraging the necessary technology to bring underutilized cannabinoids into mainstream medicine."
Data compiled from the patented technology will provide valuable insight into personalized treatments for cancer patients and will support the discovery of new, active pharmaceutical ingredients for specific cancers. Ultimately, the data could allow practitioners to precisely tailor cannabinoid therapies to an individual patient's profile and type of cancer.
Over $100 million was invested in licensing Israeli medical marijuana patents over the past two years, and the global market for medical marijuana is estimated to reach $50 billion by 2025. Cannabics anticipates this significant patent will be the first in a family of patents granted in additional countries and territories, including the United States, Australia, Brazil, Canada, China, Europe, Japan, Mexico, and South Africa."
Recent CNBX News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/15/2024 02:58:24 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:27:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/12/2024 03:13:35 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM